Efficacy and safety of flumatinib in adults with Ph-positive ALL: a prospective observational study
{{output}}
Objective: To evaluate the efficacy and safety of flumatinib, a second-generation tyrosine kinase inhibitor (TKI), combined with chemotherapy in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ... ...
